AHNS-041
GENDER DISPARITIES IN SALIVARY MALIGNANCIES: IS GENDER IMPACTING ONCOLOGICAL OUTCOMES?
Salivary
Ximena Mimica, MD, Marlena McGill, BS, Ashley Hay, MD, Daniella K Zanoni, MD, Jatin P Shah, MD, Richard J Wong, Marc A Cohen, MD, Snehal G Patel, MD, Ian Ganly, MD, PhD
Memorial Sloan Kettering Cancer Center
AHNS-042
INTRAOPERATIVE NERVE MONITORING PARAMETERS PREDICT FACIAL NERVE OUTCOME IN PAROTID SURGERY
Catherine T Haring, MD, Andrew J Rosko, MD, Susan E Ellsperman, MD, Paul Kileny, PhD, Deborah Kovatch, MA, MBA, CCCA, Bruce Edwards, AuD, Matthew E Spector, MD
University of Michigan, Department of Otolaryngology- Head & Neck Surgery
AHNS-083
SURGICAL MARGINS IN SALIVARY MALIGNANCY: WHEN IS NEAR ENOUGH, GOOD ENOUGH?
M A Hanson, MD, X Mimica, MD, M McGill, BS, J Wu, MD, D K Zanoni, MD, A Hay, MD, J P Shah, MD, R J Wong, MD, M A Cohen, MD, S G Patel, MD, I Ganly, MD, PhD
AHNS-084
THE ROLE OF ELECTIVE NECK DISSECTION IN CN0 PATIENTS WITH HIGH-GRADE PAROTID CANCER AMONG A HOSPITAL-BASED NATIONAL COHORT, 2004 – 2013.
Richard A Harbison, MD, MS1, Alan Gray1, Ted Westling2, Marco Carone1, Neal Futran1, Jeffrey J Houlton1
1University of Washington, 2University of Pennsylvania
AHNS-085
SINGLE CELL RNA-SEQUENCING REVEALS INTER-TUMORAL AND INTRA-TUMORAL HETEROGENEITY IN MYB-DRIVEN PROGRAMS IN ADENOID CYSTIC CARCINOMA
Anuraag S Parikh, MD1, Sidharth V Puram, MD, PhD2, Yotam Drier, PhD3, William C Faquin, MD, PhD1, Armida Lefranc-Torres, MD1, Jeremy D Richmon, MD1, Kevin S Emerick, MD1, Daniel G Deschler, MD1, Mark A Varvares, MD1, Bradley E Bernstein, MD, PhD3, Derrick T Lin, MD1
1Massachusetts Eye and Ear Infirmary, 2Massachusetts Eye and Ear Infirmary, Ohio State University, 3Massachusetts General Hospital
D190
INCIDENCE OF WARTHIN TUMOR IN A VETERAN POPULATION: A SHIFTING PARADIGM
Adnan S Hussaini1, Edina Paal, MD2, Sonya Malekzadeh, MD3, Jessica H Maxwell3
1Medstar Georgetown University Hospital - Department of Otolaryngology - Head & Neck Surgery, 2The George Washington University, Department of Pathology, 3Washington DC Veterans Affairs Medical Center, Department of Otolaryngology - Head & Neck Surgery
D191
RESPONSE TO LAROTRECTINIB AS PRIMARY SYSTEMIC THERAPY FOR UNRESECTABLE MAMMARY ANALOG SECRETORY CARCINOMA OF THE PAROTID GLAND
Haley N Kemp, MPAS, PAC1, Ly Nguyen1, Sandra Montez1, Diana Bell1, Filip Janku1, Maura L Gillison1, Ehab Y Hanna1, Nora Ku2, David Hong1, Xiuning Le1
1MD Anderson Cancer Center, 2Loxo Oncology, Inc
D192
A NOVEL PAROTID AND FACIAL NERVE SURGICAL SIMULATOR: DESIGN AND INITIAL VALIDATION
Fanny Gabrysz-Forget, MD, Robert W Dolan, MD, Bharat B. Yarlagadda, MD
Lahey Hospital & Medical Center
D193
LATE LOCOREGIONAL AND DISTANT METASTASES IN A LARGE LONG-TERM ADENOID CYSTIC CARCINOMA COHORT
Peter Lancione, BA1, Bhavna Kumar, MS2, Amit Agrawal, MD2, Ricardo Carrau, MD2, Stephen Kang, MD2, Enver Ozer, MD2, James Rocco, MD, PhD2, Matthew Old, MD2
1The Ohio State University College of Medicine, 2Department of Otolaryngology, The Ohio State University Wexner Medical Center
D194
PREDICTORS OF NODAL METASTASIS IN MUCOEPIDERMOID CARCINOMA OF THE UPPER AERODIGESTIVE TRACT
Viran J Ranasinghe, MD1, Linda C Magana, PhD2, Adam C Kaufman, MD, PhD1, Robert M Brody, MD1
1University of Pennsylvania, 2Thomas Jefferson University
AHNS Annual Meeting
Held during the Combined Otolaryngology Spring Meetings (COSM)
May 1-2, 2019 JW Marriott AustinAustin, TX